Oliger Christy J. Insider Trades

Insider Trading History

Track insider trading activity for Oliger Christy J.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nuvalent
Nuvalent NUVL
Director
Holding Value $915k 7,415 shares
Last Trade
Jun 16, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$425k 3,444 shares
$123.35
$123.44
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $150k 15,508 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$125k 15,508 shares
$8.06
$9.65
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $653k 17,084 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$587k 17,084 shares
$34.35
$38.20
Replimune Group
Replimune Group REPL
Director
Holding Value $508k 44,500 shares
Last Trade
Apr 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$339k 44,500 shares
$7.61
$11.42
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $0 0 shares
Last Trade
Nov 13, 2025 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$56.8k 33,390 shares
$1.70
$1.74
Nuvalent
Nuvalent NUVL
Director
Holding Value $755k 6,119 shares
Last Trade
Jun 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$462k 6,119 shares
$75.53
$123.44
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $44.4k 4,600 shares
Last Trade
May 28, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$20.6k 4,600 shares
$4.48
$9.65
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $535k 14,000 shares
Last Trade
May 14, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$297k 14,000 shares
$21.19
$38.20
Replimune Group
Replimune Group REPL
Director
Holding Value $365k 32,000 shares
Last Trade
Apr 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$269k 32,000 shares
$8.40
$11.42
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $58.1k 33,390 shares
Last Trade
Feb 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$31.1k 33,390 shares
$0.93
$1.74
LAVA Therapeutics NV
LAVA Therapeutics NV LVTX
Director
Holding Value $0 0 shares
Last Trade
Jan 01, 2025 Sale
$50.8k 53,390 shares
$0.95
$1.74
Vera Therapeutics
Vera Therapeutics VERA
Director
Holding Value $955k 25,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$963k 25,000 shares
$38.50
$38.20
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $666k 69,000 shares
Last Trade
May 29, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$996k 69,000 shares
$14.43
$9.65
Replimune Group
Replimune Group REPL
Director
Holding Value $365k 32,000 shares
Last Trade
Apr 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$247k 32,000 shares
$7.73
$11.42
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $0 0 shares
Last Trade
Sep 26, 2023 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$2.35M 13,608 shares
$172.36
$172.36
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $959k 5,565 shares
Last Trade
Jun 07, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$357k 3,819 shares
$93.61
$172.36
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $328k 34,000 shares
Last Trade
May 24, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.28M 34,000 shares
$37.50
$9.65
Replimune Group
Replimune Group REPL
Director
Holding Value $288k 25,200 shares
Last Trade
Apr 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$445k 25,200 shares
$17.66
$11.42
Reata Pharmaceuticals
Reata Pharmaceuticals RETA
Director
Holding Value $969k 5,620 shares
Last Trade
Jun 08, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$195k 5,620 shares
$34.76
$172.36
Karyopharm Therapeutics
Karyopharm Therapeutics KPTI
Director
Holding Value $231k 23,900 shares
Last Trade
May 19, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.03M 23,900 shares
$84.75
$9.65

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up